BioCentury
ARTICLE | Clinical News

Vistide data

February 5, 1996 8:00 AM UTC

GILD presented interim data from 100 AIDS patients with relapsing CMV retinitis, which showed that the maintenance dosage of 5 mg/kg was more effective than a lower dose of 3 mg/kg in delaying the progression of the disease compared to historical controls.

Data from the randomized, controlled pivotal study, presented at the Critical Issues in AIDS Research Symposia in Washington, confirmed data from an interim analysis on 60 patients presented in October. ...